|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 |
| (11) | Number of the document | 3354733 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17196203.8 |
| Date of filing the European patent application | 2009-10-20 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 106956 P | 2008-10-20 | US | |
| 115738 P | 2008-11-18 | US | |
| 156670 P | 2009-03-02 | US | |
| 185545 P | 2009-06-09 | US | |
| 242783 P | 2009-09-15 | US | |
| 244794 P | 2009-09-22 | US |
| (72) |
SAH Dinah, Wen-yee, US
HINKLE, Gregory, US
ALVAREZ, Rene, US
MILSTEIN, Stuart, US
CHEN, Qingmin, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN |
| COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN |